Tokyo 2020 – a pivotal moment for CBD in sport?
Despite a host country in an official state of emergency, the Olympics will reportedly go ahead this summer. This is against the wishes of 80 per cent of the Japanese […]
24 results for “2020”
Despite a host country in an official state of emergency, the Olympics will reportedly go ahead this summer. This is against the wishes of 80 per cent of the Japanese […]
While Covid-19 has obviously dominated the headlines this year, 2020 has also featured some major developments in the world of cannabis, from research to reclassification. Here, Cannabis Health News looks […]
Bridging the gap between spirituality and wellness We’re already well aware of the benefits of regular meditation, and the trend for incorporating therapeutic and spiritual practices into our everyday lives […]
Understanding the difference between legal treatment and workplace safety concerns.
Devon Partnership NHS Trust has approved procedures for patients to continue taking their prescribed cannabis-based medications while in hospital.
The CBD manufacturer has received a draft positive scientific opinion from EFSA on its Novel Food application.
Inhaled cannabis was associated with ‘large, sustained, and statistically robust improvements’ in pain and disability.
Cannabis-derived molecules could help relieve chronic pain without the psychoactive effects associated with THC.
We take a closer look at the data behind medical cannabis prescribing to examine what it can reliably show us.
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
A survey of more than 3,500 patients in Germany found that more than half were able to reduce their use of other medications.
The Hannah Deacon Campaign is calling on the government to support children unable to access medical cannabis on the NHS.
A previously unrecognised form of reporting bias may be skewing how research on medical cannabis is presented.
Last week, the first official guidance on medical cannabis for police officers in England and Wales was made public.
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
A quick rundown of the highlights so far, and what’s still left to look forward to.
From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we still need more research? […]
We unpack the science behind the ECS and its significance in a range of chronic conditions.
A new report from the General Pharmaceutical Council’s (GPhC) provides the most detailed regulatory snapshot yet of how medical cannabis is being dispensed across the UK.
A number of studies have explored whether medicinal cannabis could be used to treat some of the common symptoms.
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of the novel foods approval […]
A new survey of NHS doctors has highlighted a growing demand for alternative treatment options for complex health issues.
A Freedom of Information request has established that the NHS will publish data from its ‘registry’ by the ‘end of the year’.
Research from two separate studies has highlighted how promotional packaging and social media content can make cannabis-infused products more appealing to teens.